CHUKWUKA MORDI: Open Payments
NPI 1962708529 · DIX HILLS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,277 in 64 payments from 8 companies in 2025. Trend: 2023 $692 · 2024 $771 · 2025 $1,277
Food & beverage: $1,277
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $296 |
| Alkermes, Inc. | 18 | $287 |
| Otsuka America Pharmaceutical, Inc. | 10 | $228 |
| Lundbeck LLC | 9 | $177 |
| Supernus Pharmaceuticals, Inc. | 6 | $122 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $115 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $28 |
| Corium, LLC | 1 | $24 |
Products named: VRAYLAR, ARISTADA, ABILIFY ASIMTUFII, ABILIFY MAINTENA, Qelbree, CAPLYTA, REXULTI, Azstarys.
Industry payments across NY — which companies pay providers there.
